Close

aTyr Pharma (LIFE) Reports Top-Line Results from Resolaris Phase 1b/2 Trial

April 24, 2017 7:31 AM EDT Send to a Friend
aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login